No overview information available.
No background information available.
用于各类伴有镜下血尿和高凝状态的肾小球疾病,如肾炎、慢性肾炎、肾病综合征、早期尿毒症以及冠心病、脑梗死、脉管炎等的辅助治疗。
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|---|---|---|---|---|---|---|---|---|
国药准字H20130089 | 胶囊剂 | N/A | 0.1g | Chemical Drug | Approved | 2023/03/24 | Domestic | ||
国药准字H20080604 | 胶囊剂 | N/A | 50mg;100mg | Chemical Drug | Approved | 2023/03/09 | Domestic | ||
国药准字H20052333 | 片剂 | N/A | 0.1g | Chemical Drug | Approved | 2020/01/16 | Domestic | ||
国药准字H20103413 | 片剂 | N/A | 50mg | Chemical Drug | Approved | 2019/11/08 | Domestic | ||
国药准字H43021825 | 片剂 | N/A | 50mg | Chemical Drug | Approved | 2019/12/27 | Domestic | ||
国药准字H43021760 | 片剂 | N/A | 50mg | Chemical Drug | Approved | 2020/08/02 | Domestic | ||
国药准字H20067115 | 片剂 | N/A | 100mg | Chemical Drug | Approved | 2020/05/14 | Domestic | ||
国药准字H46020603 | 片剂 | N/A | 50mg | Chemical Drug | Approved | 2020/06/10 | Domestic | ||
国药准字H51023368 | 片剂 | N/A | 50mg | Chemical Drug | Approved | 2019/12/27 | Domestic |
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|
No TGA products found for this drug